Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2026-02-13 @ 10:52 AM
Study NCT ID:
NCT02580305
Status:
COMPLETED
Last Update Posted:
2023-06-09
First Post:
2015-10-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
Sponsor:
Suven Life Sciences Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2019-11-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-07
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-17
First Submit QC Date:
None
Study First Post Date:
2015-10-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-04-17
Results First Submit QC Date:
None
Results First Post Date:
2023-06-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-11-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-05-16
Last Update Post Date:
2023-06-09
Last Update Post Date Type:
ACTUAL